Injesta OXY injection solution 12,5% 5 ampl 1ml Progesterone Инжеста Окси

Injesta OXY Indications

Pathological processes caused by luteal insufficiency, danger of miscarriage; primary and secondary amenorrhea; polymenorrhea; dysfunctional uterine bleeding; hyperplastic processes in endometrium of endometriosis. 

Contraindications

- Hypersensitivity to the drug;

- Abnormal liver function, liver disease (hepatitis, cirrhosis), benign hyperbilirubinemia, cholestatic jaundice during pregnancy or history;

- Renal failure;

- Malignant tumors of breast and genitals;

- Pregnancy or ectopic pregnancy, froze, a history of vaginal bleeding of unknown origin, post abortion;

- Nervous disorders with symptoms of depression, tachycardia;

- Active arterial or venous thromboembolism, severe thrombophlebitis, or a history of these conditions;

- Porphyria.

Dosage & Administration

Adult women only. Enter drug intramuscularly. For prevention and treatment of threatened miscarriage administered by 125-250 mg (1-2 ml of 12.5% ​​solution) 1 every week. Injesta OXY is applied only in the first trimester of pregnancy.

When amenorrhea (primary and secondary) drug administered immediately after discontinuation of estrogen drugs. Enter Injesta OXY 250 mg single dose or in two divided doses.

In order to normalize the menstrual cycle (when polymenorrhea, dysfunctional uterine bleeding) Inzhesta Oaks administered at a dose of 62,5-125 mg (0.5-1 ml of 2.5% solution) at 20-22-day cycle.

Women with endometrial hyperplasia (in the absence of hormonally active ovarian tumors) under the age of 45 years in the menstrual cycle phase I prescribe estrogen (ethinyl estradiol 0.05 mg per day with a 5-to 25-day cycle) and Injesta OXY 1 ml 12 5% solution of 1 times a week at 5, 12 and 19-day cycle for cycles 4-5. Women aged '45 to enter only Injesta OXY 2 ml 12.5% ​​solution of 1 times a week for 6-8 menstrual cycles.